相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
详见官方网站
- 亚型:
详见官方网站
- 形态:
冻干粉/浓缩液
- 保存条件:
-20℃
- 克隆性:
多克隆
- 标记物:
详见说明书
- 适应物种:
详见说明书
- 宿主:
详见官方网站
- 应用范围:
详见官方网站
- 浓度:
1mg/ml
- 抗体英文名:
TNF Receptor-associated Factor 2 (TRAF2) Rabbit anti-Human Polyclonal (N-Terminus) Antibody
- 规格:
100ug,200ug,1mg
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Production, Purification, and Characterization of scFv TNF Ligand Fusion Proteins
attractive for cancer treatment. N-terminal fusion of scFvs does not interfere with the receptor binding capabilities of TNF ligands and thus allows the straightforward generation of scFv TNF ligand fusion proteins. We report here a protocol
Overview of Receptor Allosterism
modulators on orthosteric ligand dissociation kinetics. (A ) Enhancement of the dissociation rate of [3 H]yohimbine from the human α2A receptor expressed in CHO cell membranes by the modulator 5‐( N ‐ethyl‐ N ‐isopropyl)‐amiloride (EPA). Data taken
TRAF‐Mediated TNFR‐Family Signaling
. Schwenzer, R., Siemienski, K., Liptay, S., Schubert, G., Peters, N., Scheurich, P., Schmid, R.M., and Wajant, H. 1999. The human tumor necrosis factor (TNF) receptor‐associated factor 1 gene (TRAF
技术资料暂无技术资料 索取技术资料








